Reply to “Compliance with Antimicrobial Therapy for Buruli Ulcer”
Open Access
- 1 October 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (10) , 6341
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Compliance with Antimicrobial Therapy for Buruli UlcerAntimicrobial Agents and Chemotherapy, 2014
- Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment ofMycobacterium ulceransDiseaseAntimicrobial Agents and Chemotherapy, 2010
- Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trialThe Lancet, 2010
- Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer ( Mycobacterium ulcerans Disease)Antimicrobial Agents and Chemotherapy, 2007
- Buruli Ulcer Recurrence, BeninEmerging Infectious Diseases, 2005
- Effectiveness of Excision of Pre-Ulcerative Buruli Lesions in Field Situations in a Rural District in GhanaTropical Doctor, 1998
- Opportunities for the elimination of tuberculosis.1986
- Patient Compliance: The Most Serious Remaining Problem in the Control of Tuberculosis in the United StatesChest, 1979
- Patient Compliance: The Most Serious Remaining Problem in the Control of Tuberculosis in the United StatesChest, 1979
- A CONTROLLED TRIAL OF THE TREATMENT OF MYCOBACTERIUM ULCERANS INFECTION WITH CLOFAZIMINEThe Lancet, 1973